PMD insider filings
PSYCHEMEDICS CORP — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-12-17. Screen PMD transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for PMD between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — PSYCHEMEDICS CORP
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-17 | 4 | Powell Anderson Capital Partners LLC — 10% owner PACP Jupiter LLC — 10% owner POWELL ANDERSON CAPITAL LP — 10% owner Lindsay Richard Adam — 10% owner | Purchase (P): 80,000 @ $1.88 · Purchase (P): 30,000 @ $1.97 · Purchase (P): 30,000 @ $1.97 · Purchase (P): 9,850 @ $1.87 · Purchase (P): 9,850 @ $1.87 | EDGAR |
| 2024-12-12 | 4 | Kamin Peter — Director, 10% owner | Sale (S): 320,708 @ $2.35 | EDGAR |
| 2024-12-12 | 4 | Powell Anderson Capital Partners LLC — 10% owner PACP Jupiter LLC — 10% owner POWELL ANDERSON CAPITAL LP — 10% owner Lindsay Richard Adam — 10% owner | Purchase (P): 7,473 @ $2.59 · Purchase (P): 4,518 @ $2.71 · Purchase (P): 75,000 @ $2.67 | EDGAR |
| 2024-12-05 | 4 | Kamin Peter — Director, 10% owner | Purchase (P): 1,409,712 @ $2.35 | EDGAR |
| 2024-01-24 | 4 | Mehalik Daniella — Vice President - Finance | Grant/award (A): 35,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2023-09-25 | 4 | Shoemaker Shannon — Chief Revenue Officer | Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-08-22 | 4 | Weisenhoff Michael | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2023-08-21 | 4 | Kamin Peter — Director, 10% owner | Grant/award (A): 14,000 @ $0 | EDGAR |
| 2023-08-21 | 4 | Hullinger Brian — President & CEO, Director | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-08-21 | 4 | Doucot Charles M — Executive Vice President | Sale (S): 12,700 @ $4.66 | EDGAR |
| 2023-08-21 | 4 | Davis Robyn C — Director | Grant/award (A): 14,000 @ $0 | EDGAR |
| 2023-08-21 | 4 | Reynolds Andrew — Director | Grant/award (A): 14,000 @ $0 | EDGAR |
| 2023-08-21 | 4 | NEVIN DARIUS G — Director | Grant/award (A): 14,000 @ $0 | EDGAR |
| 2023-05-24 | 4 | Doucot Charles M — Executive Vice President | Tax withholding (F): 825 @ $4.93 | EDGAR |
| 2023-05-24 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Tax withholding (F): 375 @ $4.93 | EDGAR |
| 2023-05-24 | 4 | KUBACKI RAYMOND C JR — Chairman, CEO & President, Director | Tax withholding (F): 1,500 @ $4.93 | EDGAR |
| 2023-05-16 | 4 | Doucot Charles M — Executive Vice President | Tax withholding (F): 900 @ $4.87 | EDGAR |
| 2023-05-16 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Tax withholding (F): 337 @ $4.87 | EDGAR |
| 2023-05-16 | 4 | KUBACKI RAYMOND C JR — Chairman, CEO & President, Director | Tax withholding (F): 1,725 @ $4.87 | EDGAR |
| 2022-12-20 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Purchase (P): 100 @ $4.95 | EDGAR |
| 2022-11-15 | 4 | Doucot Charles M — Executive Vice President | Tax withholding (F): 1,350 @ $6.18 | EDGAR |
| 2022-11-15 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Tax withholding (F): 525 @ $6.18 | EDGAR |
| 2022-11-15 | 4 | KUBACKI RAYMOND C JR — Chairman, CEO & President, Director | Tax withholding (F): 2,625 @ $6.18 | EDGAR |
| 2022-08-16 | 4 | Kamin Peter — Director, 10% owner | Grant/award (A): 9,000 @ $0 | EDGAR |
| 2022-08-16 | 4 | NEVIN DARIUS G — Director | Grant/award (A): 9,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | Limbek Andrew — Vice President & Controller | Grant/award (A): 7,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | Doucot Charles M — Executive Vice President | Grant/award (A): 11,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | Davis Robyn C — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | Reynolds Andrew — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | TOMENSON WALTER S — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Grant/award (A): 5,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | KUBACKI RAYMOND C JR — Chairman, CEO & President, Director | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2022-05-24 | 4 | WEINERT FRED J — Director | Grant/award (A): 12,000 @ $0 | EDGAR |
| 2022-05-17 | 4 | Limbek Andrew — Vice President & Controller | Tax withholding (F): 600 @ $6.44 | EDGAR |
| 2022-05-17 | 4 | Doucot Charles M — Executive Vice President | Tax withholding (F): 900 @ $6.44 | EDGAR |
| 2022-05-17 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Tax withholding (F): 337 @ $6.44 | EDGAR |
| 2022-05-17 | 4 | KUBACKI RAYMOND C JR — Chairman, CEO & President, Director | Tax withholding (F): 1,725 @ $6.44 | EDGAR |
| 2022-04-21 | 4 | Kamin Peter — 10% owner | Purchase (P): 11,706 @ $6.52 · Purchase (P): 15,152 @ $6.52 · Purchase (P): 627 @ $6.52 · Purchase (P): 8,100 @ $6.72 · Purchase (P): 1,950 @ $6.72 · Purchase (P): 3,808 @ $6.72 · +1 more | EDGAR |
| 2022-04-11 | 4 | Kamin Peter — 10% owner | Purchase (P): 3,000 @ $6.68 · Purchase (P): 4,000 @ $6.79 | EDGAR |
| 2022-04-07 | 4 | Reynolds Andrew — Director | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-04-07 | 4 | WEINERT FRED J — Director | Option exercise (M): 1,000 @ $4.07 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2022-03-31 | 4/A | Kamin Peter — 10% owner | Purchase (P): 7,814 @ $6.88 · Purchase (P): 4,589 @ $6.92 | EDGAR |
| 2022-03-18 | 4 | Kamin Peter — 10% owner | Purchase (P): 4,000 @ $6.51 | EDGAR |
| 2022-01-27 | 4 | Limbek Andrew — Vice President & Controller | Tax withholding (F): 37 @ $7.39 | EDGAR |
| 2021-11-16 | 4 | Doucot Charles M — Executive Vice President | Tax withholding (F): 1,575 @ $8.50 | EDGAR |
| 2021-11-16 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Tax withholding (F): 612 @ $8.50 | EDGAR |
| 2021-11-16 | 4 | KUBACKI RAYMOND C JR — Chairman, CEO & President, Director | Tax withholding (F): 3,062 @ $8.50 | EDGAR |
| 2021-05-14 | 4 | SCHAFFER MICHAEL I — VP of Laboratory Operations | Grant/award (A): 4,500 @ $0 | EDGAR |
| 2021-05-14 | 4 | KUBACKI RAYMOND C JR — Chairman, CEO & President, Director | Grant/award (A): 23,000 @ $0 | EDGAR |
| 2021-05-14 | 4 | WEINERT FRED J — Director | Grant/award (A): 11,000 @ $0 | EDGAR |
Recent 8-K events — PSYCHEMEDICS CORP
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-12-10 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-12-03 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-25 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-12 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-03 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2024-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs